The Latest: FDA OKs third antibody drug for COVID-19 cases
|
May 26, 2021 3:27 PM
WASHINGTON — U.S. health officials have granted emergency authorization to a third antibody drug to help reduce hospitalizations and deaths due to COVID-19.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
